Cargando…
Dramatic Efficacy of Interferon and Vemurafenib on Psychiatric Symptoms Revealing BRAF(V600E) -Mutated Erdheim–Chester Disease: A Case Report
Erdheim–Chester disease (ECD) is a rare condition with underestimated neurological involvement. Mild psychiatric symptoms such as mood swings have been rarely described in the clinical spectrum of neuro-ECD. We here describe the first patient with psychiatric manifestations of delirium revealing ECD...
Autores principales: | Razanamahery, Jérôme, Abdallahoui, Maroua, Chabridon, Guillaume, Fromont, Agnès, Tarris, Georges, Idbaih, Ahmed, Comby, Pierre Olivier, Godard, Francois, Haroche, Julien, Audia, Sylvain, Bonnotte, Bernard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9299438/ https://www.ncbi.nlm.nih.gov/pubmed/35874752 http://dx.doi.org/10.3389/fimmu.2022.918613 |
Ejemplares similares
-
Vemurafenib for BRAF V600‐mutant Erdheim–Chester disease presenting with bilateral orbital involvement
por: Wang, Xiaomeng, et al.
Publicado: (2023) -
Excellent response of intramedullary Erdheim-Chester disease to vemurafenib: a case report
por: Tzoulis, Charalampos, et al.
Publicado: (2015) -
FDA Approval Summary: Vemurafenib for the Treatment of Patients with Erdheim‐Chester Disease with the BRAFV600 Mutation
por: Oneal, Patricia A., et al.
Publicado: (2018) -
Impact of BRAF(V600E)
mutation on aggressiveness and outcomes in adult clonal histiocytosis
por: Razanamahery, Jerome, et al.
Publicado: (2023) -
Orbital and chorioretinal manifestations of Erdheim-Chester disease treated with vemurafenib
por: Huang, Laura C., et al.
Publicado: (2018)